Skip to main content
. Author manuscript; available in PMC: 2012 Sep 15.
Published in final edited form as: Cancer Res. 2012 Jan 20;72(6):1557–1567. doi: 10.1158/0008-5472.CAN-11-3596

Table 1.

Tumor histology, # of nodules, precursor lesions found, sites of metastasis, and age.

ID Age (wk) Tumor Type Size (cm) Cancer Precursor Gross metastasis/invasion

KrasG12D P53L/L 100 9.0 HCC 1.5 none None

460 11.7 Mixed 0.5 IPBN Lung, spleen, under liver diaphragm, stomach, pancreas
Mixed 0.4
Mixed 1.3

199 13.1 CC 1.5 unknown unknown

444 15.7 CC 2.0 unknown Diaphragm, intestine, pancreas, lung

537 18.1 CC 1.0 VMC Lung, diaphragm, lymph nodes
CC 0.5

518 18.3 CC 0.4 none Lymph nodes, stomach

258 18.4 CC 0.3 IPBN None
Mixed 0.6
CC 1.3

449 18.7 CC 0.5 VMC Lower lymph nodes

254 19.4 HCC 3.0 unknown None

335 19.6 CC 1.0 VMC Lymph nodes, intestine

520 19.9 CC 0.5 VMC Diaphragm

257 23.3 HCC 1.0 none Lung
CC 0.3

476 32.0 CC 0.5 none Lungs, lymph nodes

719 17.6 CC 1.0 IPBN Lung, diaphragm, lymph nodes
CC 2.0
CC 2.0

KrasG12D P53L/+ 232 31.9 HCC 2.0 none None

339 37.6 CC 2.0 none Lung
Mixed 2.5

231 39.1 CC 1.0 none Intestine, pancreas

421 41.9 HCC 0.3 none None

425 45.1 CC 2.0 VMC Lungs, pancreas, lymph nodes, stomach

338 51.0 HCC 1.0 none None

344 61.7 CC 2.2 IPBN Lungs, lymph nodes

408 61.7 CC 1.6 none Lungs, lymph nodes, intestine

KrasG12D 495 35.7 CC 2.0 unknown None
HHS Vulnerability Disclosure